| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785414 | Brachytherapy | 2018 | 8 Pages |
Abstract
In vivo dosimetry using microMOSFETs in MUPIT and Utrecht Interstitial Fletcher applicators has proved to be feasible. Reimaging should be performed after detection of differences larger than 10% between predicted and measured dose to verify the applicator configuration. Movement of the applicator relative to the target or organs at risk is undetectable with this method.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marion P.R. Van Gellekom, Richard A.M. Canters, Frank J.W.M. Dankers, Agnes Loopstra, Elzbieta M. van der Steen-Banasik, Marie A.D. Haverkort,